Guoyi Yilian Secures Investment from Tianzhu Government of Shunyi District to Accelerate Regional Layout of Traditional Chinese Medicine Achievement Transformation System

VCBeat has learned that Beijing Guoyi Yilian Health Technology Co., Ltd. (hereinafter referred to as “Guoyi Yilian”) recently secured investment from the “Beijing Guomen Tongxiang Equity Investment Fund,” established under the leadership of the Tianzhu Government of Shunyi District, Beijing. The company’s valuation reached RMB 200 million in this funding round. This collaboration will primarily support Guoyi Yilian in deepening the construction of a system for translating renowned traditional Chinese medicine (TCM) clinical prescriptions into practical applications within Shunyi District. Both parties will work together to build a TCM achievement translation center based in Tianzhu, Shunyi, with nationwide reach and demonstrative, leading value.

Guoyi Yilian is a high-tech enterprise focused on the commercialization of cutting-edge scientific and technological achievements in biopharmaceuticals and medical devices, boasting strong technical innovation capabilities and clear market prospects. Leveraging authoritative research institutions and resources from renowned senior Traditional Chinese Medicine (TCM) practitioners, the company is dedicated to the systematic translation of clinical TCM achievements and has established significant technical advantages and a comprehensive business layout in the field of transdermal drug delivery. Its independently developed external TCM therapy carrier technology and supporting precision instruments have supported the construction of external therapy centers in nearly 10,000 hospitals across China, effectively enhancing the standardization and accessibility of external TCM therapy services. The company’s core transdermal drug delivery project secured Series A financing from the Tongrentang Fund in 2024, fully demonstrating the project’s technological advancement and commercial potential, while laying a solid foundation for the company’s further development in Tianzhu.

Officials from the Indian government pointed out:“Guoyi Medical Alliance holds significant advantages in the transformation of traditional Chinese medicine (TCM) achievements and the integration of the industrial chain. Its business model and technical capabilities are highly aligned with the development plan for the big health industry in Shunyi District. Through strategic investment from the Beijing Guomen Tongxiang Equity Investment Fund, Guoyi Medical Alliance will be effectively propelled to achieve technology implementation, industrial convergence, and service upgrades within the region, thereby fostering the principled innovation of TCM and supporting the high-quality development of the regional economy.”

Ms. Zhao Xin, Founder, Chairwoman, and CEO of Guoyi Medical Alliance, stated:“We extend our gratitude to the Tianzhu Government and the Beijing Guomen Tongxiang Equity Investment Fund for their recognition and support of Guoyi Medical Alliance. The funds from this round will be focused on building scenarios for the translation of traditional Chinese medicine (TCM) achievements in Shunyi District, further enhancing the accessibility and precision of TCM services. We look forward to collaborating with local governments to jointly create a demonstrative model for regional innovation and translation in TCM.”

This collaboration marks a critical step for Guoyi Medical Alliance in policy coordination and regional resource integration. The company will continue to leverage its integrated “technology + operations + distribution” translation system to accelerate the transition of traditional Chinese medicine (TCM) clinical achievements into large-scale applications, thereby injecting sustained momentum into public health and the revitalization of the TCM industry.